All manuscripts
Publications NK Cells

S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice

Published Journal Journal of Virology

Share
15 pages S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice — Journal of Virology, 2024

Overview

This study demonstrates that S309-CAR-NK cells can bind to SARS-CoV-2 variants and reduce viral loads in humanized ACE2-NSG mice. Primary NK cell expansion and CAR-NK cell maintenance were performed using G-Rex® wells.

What this paper found

S309-CAR-NK cells reduced SARS-CoV-2 viral loads in the lungs of hACE2-NSG mice by roughly tenfold compared with vehicle. Primary NK cells from eight PBMC donors were transduced with an SFG vector encoding S309 scFv, a CD28 transmembrane domain, CD28, 4-1BB and CD3 zeta signaling domains and secreted IL-15, giving about 90% NK purity and 70% CAR expression. The CAR-NK cells bound pseudotyped Delta and Mu spike and recombinant Omicron spike protein, competitively blocked pseudovirus binding to 293T-hACE2 cells, and lysed A549 cells expressing Delta, Mu and Omicron spike more efficiently than S2E12-CAR-NK cells. Mice received 1 x 10^5 PFU intranasally and three intravenous doses of 5 x 10^6 cells, with lungs analyzed on day 10.

Note: Preclinical work in cell lines and mice. The authors state that variants other than Delta, Mu and Omicron were not tested, and present the work as a proof of concept for off-the-shelf CAR-NK therapy against infectious disease.

These results altogether indicate that S309-CAR-NK cells may effectively and specifically target SARS-CoV-2-infected cells. — Minh Tuyet Ma, Qingkui Jiang, Chih-Hsiung Chen, Saiaditya Badeti, Xuening Wang, Cong Zeng, Deborah Evans, Brittany Bodnar, Salvatore A. E. Marras, Sanjay Tyagi, Preeti Bharaj, Ghassan Yehia, Peter Romanienko, Wenhui Hu, Shan-Lu Liu, Lanbo Shi, Dongfang Liu, Journal of Virology

Study details

Authors
Minh Tuyet Ma, Qingkui Jiang, Chih-Hsiung Chen, Saiaditya Badeti, Xuening Wang, Cong Zeng, Deborah Evans, Brittany Bodnar, Salvatore A. E. Marras, Sanjay Tyagi, Preeti Bharaj, Ghassan Yehia, Peter Romanienko, Wenhui Hu, Shan-Lu Liu, Lanbo Shi, Dongfang Liu
Institution
Department of Pathology, Immunology, and Laboratory Medicine, Newark, New Jersey, USA · School of Graduate Studies, Rutgers Biomedical and Health Sciences, Newark, New Jersey, USA · Center for Immunity and Inflammation, New Jersey Medical School, Rutgers-The State University of New Jersey, Newark, New Jersey, USA · Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Rutgers, The State University of New Jersey, Newark, New Jersey, USA · Department of Anatomy and Neurobiology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA · Center for Retrovirus Research, The Ohio State University, Columbus, Ohio, USA · Center for Metabolic Disease Research, Department of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA · Genome Editing Shared Resource, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA · Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA
Journal
Journal of Virology
Year
2024
PMID / PMC
PMID: 38767356 · PMC
Cell type(s)
NK Cells
Application area
Infectious disease
Study phase
Preclinical

How G-Rex® was used

Primary NK cells were expanded in a G-Rex® well, where 5 × 10^6 PBMCs were cocultured with 10 × 10^6 221-mIL21 feeder cells in R-10 medium supplemented with 200 U/mL recombinant hIL-2 and 5 ng/mL recombinant hIL-15. After transduction with the S309 or S2E12 CAR construct, the cells were returned to a G-Rex® well and cultured in the same IL-2 and IL-15 supplemented R-10 medium. The medium was changed every 3 to 4 days to maintain the NK and CAR-NK cells. This expansion yielded an average of 90% NK cell purity and 70% CAR expression from the PBMCs of eight donors.

Note: Transduction itself was performed outside the gas-permeable vessel, in a RetroNectin-coated 24-well plate, before the cells were returned to culture.

Explore related

Full citation

Ma MT, Jiang Q, Chen CH, et al. S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice. J Virol. 2024;98(6):e0003824.

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →